Cosmin Stefan Butnarasu (Cosmin Butnarasu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Pharmaceutics

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Molecular pharmaceutics

Science translational medicine

University of Turin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Turin

Italy

PhD student :: Molecular Biotechnology and Health Science

Publications

Cosmin Stefan Butnarasu, Olga Valentina Garbero, Paola Petrini, Livia Visai, Sonja Visentin
Permeability Assessment of a High-Throughput Mucosal Platform. Pharmaceutics 15 (2) (2023)
Cosmin Stefan Butnarasu, Olga Valentina Garbero, Paola Petrini, Livia Visai, Sonja Visentin
Permeability Assessment of a High-Throughput Mucosal Platform. Pharmaceutics 15 (2) (2023)
Ann-Christin Jacobsen, Sonja Visentin, Cosmin Stefan Butnarasu, Paul C Stein, Massimiliano Pio di Cagno
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies. Pharmaceutics 15 (2) (2023)
Ann-Christin Jacobsen, Sonja Visentin, Cosmin Stefan Butnarasu, Paul C Stein, Massimiliano Pio di Cagno
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies. Pharmaceutics 15 (2) (2023)
Ann-Christin Jacobsen, Sonja Visentin, Cosmin Stefan Butnarasu, Paul C Stein, Massimiliano Pio di Cagno
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies. Pharmaceutics 15 (2) (2023)
Cosmin Stefan Butnarasu, Olga Valentina Garbero, Paola Petrini, Livia Visai, Sonja Visentin
Permeability Assessment of a High-Throughput Mucosal Platform. Pharmaceutics 15 (2) (2023)
Ann-Christin Jacobsen, Sonja Visentin, Cosmin Stefan Butnarasu, Paul C Stein, Massimiliano Pio di Cagno
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies. Pharmaceutics 15 (2) (2023)
Cosmin Stefan Butnarasu, Olga Valentina Garbero, Paola Petrini, Livia Visai, Sonja Visentin
Permeability Assessment of a High-Throughput Mucosal Platform. Pharmaceutics 15 (2) (2023)
Martin Kretschmer, Rafael Ceña-Diez, Cosmin Stefan Butnarasu, Valentin Silveira, Illia Dobryden, Sonja Visentin, Per Berglund, Anders Sönnerborg, Oliver Lieleg, Thomas Crouzier, Hongji Yan
Synthetic Mucin Gels with Self-Healing Properties Augment Lubricity and Inhibit HIV-1 and HSV-2 Transmission. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (32) (2022)
Cosmin Stefan Butnarasu, Carlotta Pontremoli, Maria Jesus Moran Plata, Nadia Barbero, Sonja Visentin
Squaraine Dyes as Fluorescent Turn-on Probes for Mucins: A Step Toward Selectivity † . Photochemistry and photobiology (2022)
Alessandra Ghigo, Alessandra Murabito, Valentina Sala, Anna Rita Pisano, Serena Bertolini, Ambra Gianotti, Emanuela Caci, Alessio Montresor, Aiswarya Premchandar, Flora Pirozzi, Kai Ren, Angela Della Sala, Marco Mergiotti, Wito Richter, Eyleen de Poel, Michaela Matthey, Sara Caldrer, Rosa A Cardone, Federica Civiletti, Andrea Costamagna, Nancy L Quinney, Cosmin Stefan Butnarasu, Sonja Visentin, Maria Rosaria Ruggiero, Simona Baroni, Simonetta Geninatti Crich, Damien Ramel, Muriel Laffargue, Carlo Gabriele Tocchetti, Renzo Levi, Marco Conti, Xiao-Yun Lu, Paola Melotti, Claudio Sorio, Virginia De Rose, Fabrizio Facchinetti, Vito Fanelli, Daniela Wenzel, Bernd K Fleischmann, Marcus Alexander Mall, Jeffrey M Beekman, Carlo Laudanna, Martina Gentzsch, Gergely László Lukács, Nicoletta Pedemonte, Emilio Hirsch
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases. Science translational medicine 14 (638) (2022)
Cosmin Stefan Butnarasu, Giulia Caron, Daniela Peneda Pacheco, Daniela Peneda Pacheco, Sonja Visentin
Cystic Fibrosis Mucus Model to Design More Efficient Drug Therapies. Molecular pharmaceutics 19 (2) (2021)
Daniela Peneda Pacheco, Cosmin Stefan Butnarasu, Francesco Briatico Vangosa, Laura Pastorino, Livia Visai, Sonja Visentin, Paola Petrini
Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery. Journal of materials chemistry. B 7 (32) (2020)
Nadia Barbero, Cosmin Stefan Butnarasu, Sonja Visentin, Claudia Barolo
Squaraine Dyes: Interaction with Bovine Serum Albumin to Investigate Supramolecular Adducts with Aggregation-Induced Emission (AIE) Properties. Chemistry, an Asian journal 14 (6) (2019)

Cosmin Stefan Butnarasu.css-eqlu8i{font-size:small;padding-left:4px;} (Cosmin Butnarasu)

Publication Activity (10 Years)

Top Topics

Top Venues

Cosmin Stefan Butnarasu (Cosmin Butnarasu)